Cost and revenue dynamics of clinical trials in state-owned hospitals (2019-2022)

Yulia Nedelcheva () and Miroslav Nedelchev ()
Additional contact information
Yulia Nedelcheva: Faculty of Economics, South-West University "Neofit Rilski", Blagoevgrad
Miroslav Nedelchev: Medical University, Sofia

Economics and Management, 2024, vol. 21, issue 1, 47-54

Abstract: Objective: The object of the article is to overview the cost and revenue dynamics of clinical trials conducted in state-owned hospitals. Material and methods: We have created a unique database of clinical trials from public registers of competent authorities. Our overview is based on the protocol content of 550 clinical trials conducted in 62 Bulgarian state-owned hospitals (a total 1,297 medical sites) in the period from 2019 to2022. Results: In the new reality, reduced budget and declined state funding, the attitudes of state-owned hospitals are shifted to the benefits of clinical trials. The primary motive for state-owned hospitals to conduct clinical trials is not revenue, but rather access to new pharmaceutical products and treatment methods.

Keywords: Bulgaria; trial sites; cost-benefit analysis; health care market (search for similar items in EconPapers)
JEL-codes: D61 H51 I11 (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://em.swu.bg/images/SpisanieIkonomikaupload/S ... venue%20dymanics.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:neo:journl:v:21:y:2024:i:1:p:47-54

DOI: 10.37708/em.swu.v21i1.4

Access Statistics for this article

More articles in Economics and Management from Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD Contact information at EDIRC.
Bibliographic data for series maintained by Vladislav Krastev ().